Improved treatment planning for COMS eye plaques

International Journal of Radiation Oncology Biology Physics

Volumn 61, Issue 4, 2005, Pages 1227-1242

  Astrahan, Melvin A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

103Pd; 125I; Dosimetry; Eye plaque; Seed carrier; Silastic

Indexed keywords

ANISOTROPY; APPROXIMATION THEORY; ATTENUATION; DOSIMETRY; MONTE CARLO METHODS; PHOTOELECTRICITY; TUMORS;

BRACHYTHERAPY; COLLABORATIVE OCULAR MELANOMA STUDY (COMS); PHOTOELECTRIC ABSORPTION; SILASTIC SEED CARRIERS;

RADIOTHERAPY;

IODINE 125;

ABSORPTION SPECTROSCOPY; ANISOTROPY; ARTICLE; CHOROID MELANOMA; DOSE CALCULATION; DOSIMETRY; ELECTROCHEMISTRY; GEOMETRY; PHOTOCHEMISTRY; PRIORITY JOURNAL; TREATMENT PLANNING;

ALGORITHMS; ANISOTROPY; BRACHYTHERAPY; CHOROID NEOPLASMS; DENTAL ALLOYS; HUMANS; IODINE RADIOISOTOPES; PALLADIUM; RADIOISOTOPES; RADIOTHERAPY DOSAGE;

EID: 14844310231     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.09.062     Document Type: Article

References (29)

1. Collaborative Ocular Melanoma Study Group The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma III. Initial mortality findings. COMS Report No. 18 Arch Ophthalmol 119 2001 969 982
2. R.W. Kline, P.D. Yeakel Ocular melanoma, I-125 plaques [Abstract] Med Phys 14 1987 475
3. M. Astrahan, G. Luxton, G. Jozsef, T.D. Kampp, P. Liggett, M.D. Sapozink An interactive treatment planning system for ophthalmic plaque radiotherapy Int J Radiat Oncol Biol Phys 18 1990 679 687
4. S.-T. Chiu-Tsao, L.L. Anderson, K. O'Brien, L. Stabile, J.C. Liu Dosimetry for 125I seed (model 6711) in eye plaques Med Phys 20 1993 383 389
5. 125I seed eye plaque dose distribution including penumbra characteristics Med Phys 23 1996 407 418
6. A.L. Krintz, W.F. Hanson, G.S. Ibbott, D.S. Followill A reanalysis of the Collaborative Ocular Melanoma Study medium tumor trial eye plaque dosimetry Int J Radiat Oncol Biol Phys 56 2003 889 898
7. P.T. Finger, D.F. Lu, A. Buffa, D.S. De Blasio, J.L. Bosworth Palladium-103 versus iodine-125 for ophthalmic plaque radiotherapy Int J Radiat Oncol Biol Phys 27 1993 849 854
8. P.T. Finger, A. Berson, N. Tracy, A. Szechter Palladium-103 plaque radiotherapy for choroidal melanoma: An 11 year study Int J Radiat Oncol Biol Phys 54 2002 1438 1445
9. R. Nath, L.L. Anderson, G. Luxton, K.A. Weaver, J.F. Williamson, A.S. Meigooni Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM radiation therapy committee task group no 43. Med Phys 24 1995 209 234
10. Collaborative Ocular Melanoma Study Group COMS manual of procedures, Ch 12--radiation therapy, version 2/99, PB95-179693 1995 National Technical Information Service Springfield, VA
11. Hubbell JH, Seltzer SM. Tables of X-ray mass attenuation coefficients and mass energy-absorption coefficients (version 1.03). Available at: http://physics.nist.gov/PhysRefData/XrayMassCoef/cover.html. Gaithersburg, MD: National Institute of Standards and Technology; 1997. (Originally published as NISTIR 5632, National Institute of Standards and Technology, Gaithersburg, MD; 1995.) Accessed in December 2003.
12. W.V. Mayneord The significance of the röentgen Acta Int Union Against Cancer 2 1937 271
13. F.M. Khan The physics of radiation therapy 3rd ed. 2003 Lippincott Williams & Wilkins Philadelphia
14. 125I seed eye plaques Med Phys 13 1986 78 83
15. 125I for ophthalmic plaque dosimetry Med Phys 15 1988 397 400
16. 125I seed at close range Med Phys 15 1988 627 628
17. 125I seed Med Phys 17 1990 172 178
18. A. Wu, F. Krasin Film dosimetry analyses on the effect of gold shielding for iodine-125 eye plaque therapy for choroidal melanoma Med Phys 17 1990 843 846
19. 125I seeds Med Phys 20 1993 1251 1256
20. D. Flühs, M. Heintz, F. Indenkampen, C. Wieczorek, H. Kolanoski, U. Quast Direct reading measurement of absorbed dose with plastic scintillators The general concept and applications to ophthalmic plaque dosimetry Med Phys 23 1996 427 434
21. R.G. Dale Some theoretical derivations relating to the tissue dosimetry of brachytherapy nuclides, with particular reference to iodine-125 Med Phys 10 1983 176 183
22. G. Luxton, M.A. Astrahan, P. Liggett, D.L. Neblett, D.M. Cohen, Z. Petrovich Dosimetric calculations and measurements of gold plaque ophthalmic irradiators using iridium-192 and iodine-125 seeds Int J Radiat Oncol Biol Phys 15 1988 167 176
23. M. Astrahan, G. Luxton, G. Jozsef, P. Liggett, Z. Petrovich Optimization of I-125 ophthalmic plaque brachytherapy Med Phys 17 1990 1053 1057
24. M.D.C. Evans, M.A. Astrahan, R. Bate Tumor localization using fundus view photography for episcleral plaque therapy Med Phys 20 1993 769 775
25. M.A. Astrahan, G. Luxton, Q. Pu, Z. Petrovich Conformal episcleral plaque therapy Int J Radiat Oncol Biol Phys 39 1997 505 519
26. S. Knutsen, R. Hafslund, O.R. Monge Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy Int J Radiat Oncol Biol Phys 51 2001 1159 1166
27. M.A. Astrahan A patch source model for treatment planning of ruthenium ophthalmic applicators Med Phys 30 2003 1219 1228
28. J.F. Williamson, B.M. Coursey, L.A. DeWerd, W.F. Hanson, R. Nath, G. Ibbott Guidance to users of Nycomed Amersham and North American Scientific Inc I-125 interstitial sources: Dosimetry and calibration changes, recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on low-energy seed dosimetry Med Phys 26 1999 570 572
29. 125I brachytherapy Int J Radiat Oncol Biol Phys 56 2003 1373 1380